News - NeuVax


Current filters:


Popular Filters

Galena Biopharma leaps on deal with Teva for NeuVax in Israel


Shares of US biotech firm Galena Biopharma (Nasdaq: GALE) leapt 13.7% to $2.32 in pre-market trading…

BiotechnologyGalena BioPharmaLicensingnelipepimut-SNeuVaxOncologyRest of the WorldTeva Pharmaceutical IndustriesVaccines

Roche signs up to $490 million accord with PTC Thera for SMA program; and deal with Galena


Swiss drug major Roche (ROG: SIX) has signed a licensing agreement with privately-held US firm PTC Therapeutics…

Galena BioPharmaHerceptinLicensingNeuVaxOncologyPharmaceuticalPTC TherapeuticsRare diseasesResearchRoche

Back to top